Fresenius Medical Care has acquired Nephromor Dialysis Units, which runs 21 dialysis centers in Israel, from Teva Parmaceuticals and Clalit Health Services, the Israeli news agency Globes reported.

Globes estimated the transaction price to be 70–$90 million US.

Nephromor is the largest dialysis company in Israel within the private sector, according to information from the company’s website. Nephromor also provides complementary medical and paramedical services.